Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos


FEATUREDASCO SEP DigitalLearn from 22 peer-reviewed chapters and 90 self-assessment questions with answer rationales and references. Meetings ASCO Annual Meeting Best of ASCO ASCO Breakthrough Global Summit ASCO Quality Care Symposium ASCO Gastrointestinal Cancers Symposium ASCO Genitourinary Cancers Symposium Multidisciplinary Head & Neck Symposium Multidisciplinary Thoracic Cancers...

  • 123456 Profile photo of Madelyn

    Asciminib is the newest kid on the block for treatment of CML. This abstract presents week 96 update of ASCEMBL, the study that compared asciminib to bosutinib and helped obtain FDA approval for the drug.